ARROWHEAD PHARMACEUTICALS, INC. short interest in 2026
In 2026, ARROWHEAD PHARMACEUTICALS, INC.'s disclosed short interest ran from 7.80% of shares outstanding on 15 Jan 2026 to 6.56% on 15 Sep 2026, a change of -1.24 percentage points. The year's high was 9.29% on 31 Mar 2026 and its low 5.99% on 30 Jun 2026, averaging 7.79% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.81 days on 31 Aug 2026. Full history: ARROWHEAD PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 7.80% (15 Jan 2026)
- End of year
- 6.56% (15 Sep 2026)
- Change
- -1.24 pp
- High
- 9.29% (31 Mar 2026)
- Low
- 5.99% (30 Jun 2026)
- Average
- 7.79%
- Highest days to cover
- 8.81 (31 Aug 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 7.80% | 3.00 | |
| 30 Jan 2026 | 7.96% | 5.68 | |
| 13 Feb 2026 | 7.73% | 2.15 | 10-Q filed, results (8-K) |
| 27 Feb 2026 | 7.96% | 5.92 | |
| 13 Mar 2026 | 8.16% | 4.31 | |
| 31 Mar 2026 | 9.29% | 5.35 | |
| 15 Apr 2026 | 8.58% | 7.66 | |
| 30 Apr 2026 | 9.24% | 6.74 | |
| 15 May 2026 | 9.18% | 7.01 | 10-Q filed, results (8-K) |
| 29 May 2026 | 8.80% | 8.30 | |
| 15 Jun 2026 | 8.33% | 8.18 | |
| 30 Jun 2026 | 5.99% | 2.21 | |
| 15 Jul 2026 | 6.84% | 4.86 | |
| 31 Jul 2026 | 6.84% | 3.85 | |
| 14 Aug 2026 | 6.52% | 7.81 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 6.67% | 8.81 | |
| 15 Sep 2026 | 6.56% | 5.15 |
See also: ARROWHEAD PHARMACEUTICALS, INC.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.